NCI Initiative Aims to Boost CAR T-Cell Therapy Clinical Trials

NCI is developing the capability to produce cellular therapies, like CAR T cells, to be tested in cancer clinical trials at multiple hospital sites. Few laboratories and centers have the capability to make CAR T cells, which has limited the ability to test them more broadly.

from Cancer Currents: An NCI Cancer Research Blog https://ift.tt/3aqdAVG
Post a Comment (0)
Previous Post Next Post